Agile Therapeutics, Inc. - Common Stock (NQ:AGRX)Headline News about Agile Therapeutics, Inc. - Common Stock
Agile Therapeutics (NASDAQ: AGRX) Upgraded To "Buy" Rating By Analysts At Maxim Group ↗
September 27, 2023
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 22, 2023 ↗
September 22, 2023
Via Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes. By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
|
Agile Therapeutics, Inc. - Common Stock (NQ:AGRX)Headline News about Agile Therapeutics, Inc. - Common Stock
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes. By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
|